Results 231 to 240 of about 5,574 (244)

Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage

Health Affairs, 2019
Pinar Karaca-Mandic, Ronald Go, Daniel J Weisdorf   +2 more
exaly  

Bracing for the biosimilar wave

Nature Reviews Drug Discovery, 2017
exaly  

Biosimilar competition: lessons from Europe

Nature Reviews Drug Discovery, 2014
exaly  

Can next-generation antibodies offset biosimilar competition?

Nature Reviews Drug Discovery, 2012
exaly  

The Japan PDMA will require pharmaceutical companies to include risk management plans in all applications, for new drug or biosimilar products,

Reactions Weekly, 2012
openaire   +2 more sources

EMA backs approval of first biosimilar monoclonal antibodies

Nature Reviews Drug Discovery, 2013
exaly  

First biosimilar antibody nears US approval

Nature Reviews Drug Discovery, 2016
exaly  

EE339 The Biosimilars’ Economic Evaluation in Contrast With Judicializations’ Economic Impacts of the Pharmaceutical Assistance in Brazil

Value in Health
E Tanaka, GK Tanaka, L. Assunção-Costa, E Blay   +3 more
openaire   +1 more source

Have the biosimilar floodgates been opened in the United States?

Nature Reviews Drug Discovery, 2015
exaly  

What drives success for specialty pharmaceuticals?

Nature Reviews Drug Discovery, 2008
exaly